The blood–brain barrier in health and disease: Important unanswered questions

CP Profaci, RN Munji, RS Pulido… - Journal of Experimental …, 2020 - rupress.org
The blood vessels vascularizing the central nervous system exhibit a series of distinct
properties that tightly control the movement of ions, molecules, and cells between the blood …

Fiery cell death: pyroptosis in the central nervous system

BA McKenzie, VM Dixit, C Power - Trends in neurosciences, 2020 - cell.com
Pyroptosis ('fiery death') is an inflammatory type of regulated cell death (RCD), which occurs
downstream of inflammasome activation. Pyroptosis is mediated directly by the recently …

Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury

V Bellver-Landete, F Bretheau, B Mailhot… - Nature …, 2019 - nature.com
The role of microglia in spinal cord injury (SCI) remains poorly understood and is often
confused with the response of macrophages. Here, we use specific transgenic mouse lines …

[HTML][HTML] A cellular and spatial map of the choroid plexus across brain ventricles and ages

N Dani, RH Herbst, C McCabe, GS Green, K Kaiser… - Cell, 2021 - cell.com
The choroid plexus (ChP) in each brain ventricle produces cerebrospinal fluid (CSF) and
forms the blood-CSF barrier. Here, we construct a single-cell and spatial atlas of each ChP …

Roles and regulation of microglia activity in multiple sclerosis: insights from animal models

F Distéfano-Gagné, S Bitarafan, S Lacroix… - Nature Reviews …, 2023 - nature.com
As resident macrophages of the CNS, microglia are critical immune effectors of inflammatory
lesions and associated neural dysfunctions. In multiple sclerosis (MS) and its animal …

Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update

N Lotfi, R Thome, N Rezaei, GX Zhang… - Frontiers in …, 2019 - frontiersin.org
Granulocyte-macrophage colony-stimulating factor (GM-CSF) was first described as a
growth factor that induces the differentiation and proliferation of myeloid progenitors in the …

Current and emerging disease‐modulatory therapies and treatment targets for multiple sclerosis

F Piehl - Journal of Internal Medicine, 2021 - Wiley Online Library
The treatment of multiple sclerosis (MS), the most common chronic inflammatory,
demyelinating and neurodegenerative disease of the central nervous system (CNS) …

Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1β

J Komuczki, S Tuzlak, E Friebel, T Hartwig, S Spath… - Immunity, 2019 - cell.com
Pathogenic lymphocytes initiate the development of chronic inflammatory diseases. The
cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF)(encoded by Csf2) is a …

GM-CSF: a promising target in inflammation and autoimmunity

KMC Lee, AA Achuthan, JA Hamilton - ImmunoTargets and therapy, 2020 - Taylor & Francis
The cytokine, granulocyte macrophage-colony stimulating factor (GM-CSF), was firstly
identified as being able to induce in vitro the proliferation and differentiation of bone marrow …

Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood–brain barrier

J Hauptmann, L Johann, F Marini, M Kitic… - Acta …, 2020 - Springer
The proinflammatory cytokine interleukin 1 (IL-1) is crucially involved in the pathogenesis of
multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis …